{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:53:39Z","timestamp":1792086819095,"version":"4.4.0"},"reference-count":152,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,13]]},"DOI":"10.1093\/bjs\/znac284","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T10:58:56Z","timestamp":1664967536000},"page":"10-18","source":"Crossref","is-referenced-by-count":27,"title":["Pressurized intraperitoneal aerosol chemotherapy (PIPAC): updated systematic review using the IDEAL framework"],"prefix":"10.1093","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8371-0010","authenticated-orcid":false,"given":"Alice E","family":"Baggaley","sequence":"first","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London , St Mary\u2019s Hospital, London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume B R C","family":"Lafaurie","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London , St Mary\u2019s Hospital, London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0742-6464","authenticated-orcid":false,"given":"Sophia J","family":"Tate","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, Swansea Bay University Health Board , Swansea , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piers R","family":"Boshier","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London , St Mary\u2019s Hospital, London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Case","sequence":"additional","affiliation":[{"name":"Department of Cancer Services, Swansea Bay University Health Board, Swansea, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Prosser","sequence":"additional","affiliation":[{"name":"Department of Library Services, Swansea Bay University Health Board, Swansea, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Torkington","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadie E F","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H","family":"Gwynne","sequence":"additional","affiliation":[{"name":"Department of Cancer Services, Swansea Bay University Health Board, Swansea, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London , St Mary\u2019s Hospital, London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,3]]},"reference":[{"key":"2023063010592360000_znac284-B1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s004649900010","article-title":"Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator","volume":"14","author":"Reymond","year":"2000","journal-title":"Surg Endosc"},{"key":"2023063010592360000_znac284-B2","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(09)61116-8","article-title":"Surgical innovation and evaluation 3: no surgical innovation without evaluation: the IDEAL recommendations","volume":"374","author":"McCulloch","year":"2009","journal-title":"Lancet"},{"key":"2023063010592360000_znac284-B3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/bjs5.50257","article-title":"Pressurized intraperitoneal aerosol chemotherapy: a review of the introduction of a new surgical technology using the IDEAL framework","volume":"4","author":"Tate","year":"2020","journal-title":"BJS Open"},{"key":"2023063010592360000_znac284-B4","author":"IDEAL collaboration"},{"key":"2023063010592360000_znac284-B5","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","article-title":"Description of a novel approach for intraperitoneal drug delivery and the related device","volume":"26","author":"Sola\u00df","year":"2012","journal-title":"Surg Endosc"},{"key":"2023063010592360000_znac284-B6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00464-011-1964-y","article-title":"Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept","volume":"26","author":"Solass","year":"2012","journal-title":"Surg Endosc"},{"key":"2023063010592360000_znac284-B7","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1245\/s10434-015-4954-9","article-title":"Exploring the spatial drug distribution pattern of pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"23","author":"Khosrawipour","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2023063010592360000_znac284-B8","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00432-016-2234-0","article-title":"Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model","volume":"142","author":"Khosrawipour","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"2023063010592360000_znac284-B9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00464-017-5652-4","article-title":"Scintigraphic peritoneography reveals a non-uniform 99mTc-Pertechnetat aerosol distribution pattern for pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in a swine model","volume":"32","author":"Bellendorf","year":"2018","journal-title":"Surg Endosc"},{"key":"2023063010592360000_znac284-B10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12957-017-1109-4","article-title":"Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells","volume":"15","author":"Khosrawipour","year":"2017","journal-title":"World J Surg Oncol"},{"key":"2023063010592360000_znac284-B11","first-page":"29024","article-title":"Synergy between intraperitoneal aerosolization (PIPAC) and cancer nanomedicine: cisplatin-loaded polyarginine-hyaluronic acid nanocarriers efficiently eradicate peritoneal metastasis of advanced human ovarian cancer","volume":"12","author":"Shariati","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"2023063010592360000_znac284-B12","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.21873\/anticanres.12769","article-title":"Particle stability during pressurized intra-peritoneal aerosol chemotherapy (PIPAC)","volume":"38","author":"Mikolajczyk","year":"2018","journal-title":"Anticancer Res"},{"key":"2023063010592360000_znac284-B13","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1590\/s0102-865020170120000007","article-title":"A prototype single-port device for pressurized intraperitoneal aerosol chemotherapy. Technical feasibility and local drug distribution","volume":"32","author":"Seitenfus","year":"2017","journal-title":"Acta Cir Bras"},{"key":"2023063010592360000_znac284-B14","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/10717544.2021.1937382","article-title":"Development of rotational intraperitoneal pressurized aerosol chemotherapy to enhance drug delivery into the peritoneum","volume":"28","author":"Park","year":"2021","journal-title":"Drug Deliv"},{"key":"2023063010592360000_znac284-B15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1245\/s10434-016-5108-4","article-title":"In vivo feasibility of electrostatic precipitation as an adjunct to pressurized intraperitoneal aerosol chemotherapy (ePIPAC)","volume":"23","author":"Kakchekeeva","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2023063010592360000_znac284-B16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","article-title":"Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy","volume":"21","author":"Solass","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"2023063010592360000_znac284-B17","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1245\/s10434-012-2840-2","article-title":"Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"20","author":"Blanco","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"2023063010592360000_znac284-B18","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1245\/s10434-013-3039-x","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects","volume":"20","author":"Solass","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"2023063010592360000_znac284-B19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1515\/pp-2017-0018","article-title":"Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"2","author":"Willaert","year":"2017","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B20","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.ejso.2021.05.020","article-title":"Assessment of workplace environmental contamination and occupational exposure to cisplatin and doxorubicin aerosols during electrostatic pressurized intraperitoneal aerosol chemotherapy","volume":"47","author":"Roussin","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"2023063010592360000_znac284-B21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.toxlet.2018.05.031","article-title":"Occupational exposure to platinum drugs during intraperitoneal chemotherapy. Biomonitoring and surface contamination","volume":"298","author":"Ndaw","year":"2018","journal-title":"Toxicol Lett"},{"key":"2023063010592360000_znac284-B22","doi-asserted-by":"crossref","first-page":"115694","DOI":"10.1016\/j.taap.2021.115694","article-title":"Evaluation of the environmental contamination and exposure risk in medical\/non-medical staff after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy","volume":"429","author":"Larroque","year":"2021","journal-title":"Toxicol Appl Pharmacol"},{"key":"2023063010592360000_znac284-B23","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ejso.2018.05.020","article-title":"Occupational exposure to cisplatin\/oxaliplatin during pressurized intraperitoneal aerosol chemotherapy (PIPAC)?","volume":"44","author":"Ametsbichler","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"2023063010592360000_znac284-B24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1515\/pp-2016-0019","article-title":"Environmental safety during the administration of pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"1","author":"Graversen","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jviscsurg.2019.06.010","article-title":"Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in an operating room without laminar airflow","volume":"156","author":"Delhorme","year":"2019","journal-title":"J Visc Surg"},{"key":"2023063010592360000_znac284-B26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10585-018-9895-9","article-title":"Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey","volume":"35","author":"Graversen","year":"2018","journal-title":"Clin Exp Metastasis"},{"key":"2023063010592360000_znac284-B27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00280-018-3740-3","article-title":"Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report","volume":"83","author":"Siebert","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"key":"2023063010592360000_znac284-B28","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ejso.2015.06.001","article-title":"Quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"41","author":"Odendahl","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"2023063010592360000_znac284-B29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2018.05.001","article-title":"A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis","volume":"150","author":"Tempfer","year":"2018","journal-title":"Gynecol Oncol"},{"key":"2023063010592360000_znac284-B30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejca.2020.09.010","article-title":"A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers","volume":"140","author":"Dumont","year":"2020","journal-title":"Eur J Cancer"},{"key":"2023063010592360000_znac284-B31","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3390\/cancers13051060","article-title":"A phase I dose escalation study of oxaliplatin, cisplatin and doxorubicin applied as PIPAC in patients with peritoneal carcinomatosis","volume":"13","author":"Robella","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2023063010592360000_znac284-B32","first-page":"373","article-title":"First clinical data of pressurized intraperitoneal aerosol chemotherapy (PIPAC) as salvage therapy for peritoneal metastatic biliary tract cancer","volume":"38","author":"Falkenstein","year":"2018","journal-title":"Anticancer Res"},{"key":"2023063010592360000_znac284-B33","doi-asserted-by":"crossref","first-page":"e0186709","DOI":"10.1371\/journal.pone.0186709","article-title":"Pressurized intra peritoneal aerosol chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma","volume":"12","author":"Khosrawipour","year":"2017","journal-title":"PLoS One"},{"key":"2023063010592360000_znac284-B34","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1186\/s12885-020-07627-1","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for rare gynecologic indications: peritoneal metastases from breast and endometrial cancer","volume":"20","author":"Rezniczek","year":"2020","journal-title":"BMC Cancer"},{"key":"2023063010592360000_znac284-B35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/codi.13130","article-title":"Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis","volume":"18","author":"Demtr\u00f6der","year":"2016","journal-title":"Colorectal Dis"},{"key":"2023063010592360000_znac284-B36","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ejso.2017.03.019","article-title":"Pressurized intraperitoneal aerosol chemotherapy\u2014practical aspects","volume":"43","author":"H\u00fcbner","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"2023063010592360000_znac284-B37","doi-asserted-by":"crossref","first-page":"e044811","DOI":"10.1136\/bmjopen-2020-044811","article-title":"First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II)","volume":"11","author":"Lurvink","year":"2021","journal-title":"BMJ Open"},{"key":"2023063010592360000_znac284-B38","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.ejso.2017.09.010","article-title":"Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis","volume":"43","author":"Alyami","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"2023063010592360000_znac284-B39","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s11605-018-3916-5","article-title":"How to perform safe and technically optimized pressurized intraperitoneal aerosol chemotherapy (PIPAC): experience after a consecutive series of 1200 procedures","volume":"22","author":"Giger-Pabst","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"2023063010592360000_znac284-B40","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1245\/s10434-020-09332-6","article-title":"Pressurized intraperitoneal aerosol chemotherapy enhanced by electrostatic precipitation (ePIPAC) for patients with peritoneal metastases","volume":"28","author":"Taibi","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2023063010592360000_znac284-B41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejso.2019.06.028","article-title":"Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"47","author":"Alyami","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"2023063010592360000_znac284-B42"},{"key":"2023063010592360000_znac284-B43","first-page":"593","article-title":"Irradiation does not increase the penetration depth of doxorubicin in normal tissue after pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in an ex vivo model","volume":"30","author":"Khosrawipour","year":"2016","journal-title":"In Vivo"},{"key":"2023063010592360000_znac284-B44","doi-asserted-by":"crossref","first-page":"910","DOI":"10.7150\/jca.14714","article-title":"Effect of irradiation on tissue penetration depth of doxorubicin after pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in a novel ex-vivo model","volume":"7","author":"Khosrawipour","year":"2016","journal-title":"J Cancer"},{"key":"2023063010592360000_znac284-B45","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.21873\/anticanres.11008","article-title":"Evaluating the effect of Micropump\u00a9 position, internal pressure and doxorubicin dosage on efficacy of pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in an ex vivo model","volume":"36","author":"Khosrawipour","year":"2016","journal-title":"Anticancer Res"},{"key":"2023063010592360000_znac284-B46","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.21873\/anticanres.11498","article-title":"Effect of whole-abdominal irradiation on penetration depth of doxorubicin in normal tissue after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a post-mortem swine model","volume":"37","author":"Khosrawipour","year":"2017","journal-title":"Anticancer Res"},{"key":"2023063010592360000_znac284-B47","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.21873\/anticanres.12613","article-title":"Pressurized intra-peritoneal aerosol chemotherapy (PIPAC) via endoscopical microcatheter system","volume":"38","author":"Khosrawipour","year":"2018","journal-title":"Anticancer Res"},{"key":"2023063010592360000_znac284-B48","first-page":"6185313","article-title":"Increased tissue penetration of doxorubicin in pressurized intraperitoneal aerosol chemotherapy (PIPAC) after high-intensity ultrasound (HIUS)","volume":"2019","author":"Khosrawipour","year":"2019","journal-title":"Int J Surg Oncol"},{"key":"2023063010592360000_znac284-B49","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.3762\/bjnano.8.272","article-title":"Hyperthermic intracavitary nanoaerosol therapy (HINAT) as an improved approach for pressurised intraperitoneal aerosol chemotherapy (PIPAC): Technical description, experimental validation and first proof of concept","volume":"8","author":"G\u00f6hler","year":"2017","journal-title":"Beilstein J Nanotechnol"},{"key":"2023063010592360000_znac284-B50","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s00464-016-5174-5","article-title":"Technical description of the microinjection pump (MIP\u00ae) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"31","author":"G\u00f6hler","year":"2017","journal-title":"Surg Endosc"},{"key":"2023063010592360000_znac284-B51","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.201700024","article-title":"High-pressure nebulization as application route for the peritoneal administration of siRNA complexes","volume":"17","author":"Minnaert","year":"2017","journal-title":"Macromol Biosci"},{"key":"2023063010592360000_znac284-B52","doi-asserted-by":"crossref","first-page":"e2000655","DOI":"10.1002\/adhm.202000655","article-title":"Electrostatic intraperitoneal aerosol delivery of nanoparticles: proof of concept and preclinical validation","volume":"9","author":"Van de Sande","year":"2020","journal-title":"Adv Healthc Mater"},{"key":"2023063010592360000_znac284-B53","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12885-019-5658-5","article-title":"Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"19","author":"Van de Sande","year":"2019","journal-title":"BMC Cancer"},{"key":"2023063010592360000_znac284-B54","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/02656736.2019.1704891","article-title":"PIPAC versus HIPEC: cisplatin spatial distribution and diffusion in a swine model","volume":"37","author":"Davigo","year":"2020","journal-title":"Int J Hyperthermia"},{"key":"2023063010592360000_znac284-B55","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s00464-019-07076-3","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) might increase the risk of anastomotic leakage compared to HIPEC: an experimental study","volume":"34","author":"Tavernier","year":"2020","journal-title":"Surg Endosc"},{"key":"2023063010592360000_znac284-B56","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.3390\/cancers12123818","article-title":"Establishment of a mouse ovarian cancer and peritoneal metastasis model to study intraperitoneal chemotherapy","volume":"12","author":"Rezniczek","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2023063010592360000_znac284-B57","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1515\/pp-2017-0015","article-title":"Experimental pharmacokinetics evaluation of chemotherapy delivery by PIPAC for colon cancer: first evidence for efficacy","volume":"2","author":"Eveno","year":"2017","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B58","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s12885-021-07955-w","article-title":"Pressurized intra-peritoneal aerosol chemotherapy (PIPAC): increased intraperitoneal pressure does not affect distribution patterns but leads to deeper penetration depth of doxorubicin in a sheep model","volume":"21","author":"Mimouni","year":"2021","journal-title":"BMC Cancer"},{"key":"2023063010592360000_znac284-B59","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1007\/s00464-019-07043-y","article-title":"Assessment of the aerosol distribution pattern of a single-port device for intraperitoneal administration of therapeutic substances","volume":"33","author":"Seitenfus","year":"2019","journal-title":"Surg Endosc"},{"key":"2023063010592360000_znac284-B60","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/cancers12030633","article-title":"Evaluation of a novel prototype for pressurized intraperitoneal aerosol chemotherapy","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2023063010592360000_znac284-B61","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.21037\/gs-2019-ursoc-11","article-title":"Rotational intraperitoneal pressurized aerosol chemotherapy in a porcine model","volume":"10","author":"Mun","year":"2021","journal-title":"Gland Surg"},{"key":"2023063010592360000_znac284-B62","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1007\/s00464-015-4738-0","article-title":"Feasibility of hyperthermic pressurized intraperitoneal aerosol chemotherapy in a porcine model","volume":"30","author":"Jung","year":"2016","journal-title":"Surg Endosc"},{"key":"2023063010592360000_znac284-B63","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ejso.2020.06.031","article-title":"Safety, pharmacokinetics and tissue penetration of PIPAC paclitaxel in a swine model","volume":"47","author":"Tan","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"2023063010592360000_znac284-B64","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.ejso.2021.02.012","article-title":"Experimental evaluation of icodextrin delivery as pressurized aerosol (PIPAC): antiadhesive and cytotoxic effects","volume":"47","author":"Keck","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"2023063010592360000_znac284-B65","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10637-018-0641-6","article-title":"Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro","volume":"37","author":"Weinreich","year":"2019","journal-title":"Invest New Drugs"},{"key":"2023063010592360000_znac284-B66","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.7150\/jca.26860","article-title":"Effect of liposomal doxorubicin in pressurized intra-peritoneal aerosol chemotherapy (PIPAC)","volume":"9","author":"Mikolajczyk","year":"2018","journal-title":"J Cancer"},{"key":"2023063010592360000_znac284-B67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12957-019-1633-5","article-title":"Comparing the cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the proliferation of in vitro colon carcinoma cells following pressurized intra-peritoneal aerosol chemotherapy (PIPAC)","volume":"17","author":"Schubert","year":"2019","journal-title":"World J Surg Oncol"},{"key":"2023063010592360000_znac284-B68","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.21873\/invivo.12554","article-title":"Establishment of an experimental system for intraperitoneal chemotherapy in a rat model","volume":"35","author":"Park","year":"2021","journal-title":"In Vivo"},{"key":"2023063010592360000_znac284-B69","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.21873\/anticanres.15362","article-title":"Ideal nozzle position during pressurized intraperitoneal aerosol chemotherapy in an ex vivo model","volume":"41","author":"Piao","year":"2021","journal-title":"Anticancer Res"},{"key":"2023063010592360000_znac284-B70","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejpb.2021.10.001","article-title":"Exploring high pressure nebulization of Pluronic F127 hydrogels for intraperitoneal drug delivery","volume":"169","author":"Braet","year":"2021","journal-title":"Eur J Pharm Biopharm"},{"key":"2023063010592360000_znac284-B71","doi-asserted-by":"crossref","first-page":"21843","DOI":"10.1038\/s41598-021-01332-0","article-title":"Development of a rat capnoperitoneum phantom to study drug aerosol deposition in the context of anticancer research on peritoneal carcinomatosis","volume":"11","author":"G\u00f6hler","year":"2021","journal-title":"Sci Rep"},{"key":"2023063010592360000_znac284-B72","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12885-016-3004-8","article-title":"Intraperitoneal cisplatin and doxorubicin as maintenance chemotherapy for unresectable ovarian cancer: a case report","volume":"17","author":"Tempfer","year":"2017","journal-title":"BMC Cancer"},{"key":"2023063010592360000_znac284-B73"},{"key":"2023063010592360000_znac284-B74","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/pp-2016-0005","article-title":"Electrostatic precipitation pressurized intraperitoneal aerosol chemotherapy (ePIPAC): first in-human application","volume":"1","author":"Reymond","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B75","first-page":"2309","article-title":"Low-dose pressurized intraperitoneal aerosol chemotherapy (PIPAC) as an alternative therapy for ovarian cancer in an octogenarian patient","volume":"35","author":"Giger-Pabst","year":"2015","journal-title":"Anticancer Res"},{"key":"2023063010592360000_znac284-B76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4103\/ija.IJA_623_17","article-title":"Perioperative concerns and management of pressurised intraperitoneal aerosolised chemotherapy: report of two cases","volume":"62","author":"Solanki","year":"2018","journal-title":"Indian J Anaesth"},{"key":"2023063010592360000_znac284-B77","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10585-017-9849-7","article-title":"Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"34","author":"Graversen","year":"2017","journal-title":"Clin Exp Metastasis"},{"key":"2023063010592360000_znac284-B78","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.ijscr.2020.10.054","article-title":"Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): a case report of a multimodal treatment for peritoneal metastases of pancreatic origin","volume":"77S","author":"Rotolo","year":"2020","journal-title":"Int J Surg Case Rep"},{"key":"2023063010592360000_znac284-B79","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3748\/wjg.v24.i19.2130","article-title":"Pressurized intraperitoneal aerosol chemotherapy after misdiagnosed gastric cancer: case report and review of the literature","volume":"24","author":"Nowacki","year":"2018","journal-title":"World J Gastroenterol"},{"key":"2023063010592360000_znac284-B80","doi-asserted-by":"crossref","first-page":"30","DOI":"10.12659\/AOT.911905","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases in solid organ graft recipients: first experience","volume":"24","author":"Horvath","year":"2019","journal-title":"Ann Transplant"},{"key":"2023063010592360000_znac284-B81","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/pp-2021-0138","article-title":"A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"7","author":"Ezanno","year":"2022","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B82","doi-asserted-by":"crossref","first-page":"e933906","DOI":"10.12659\/AJCR.933906","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC): the first reported case in Brazil using standardized technique with the Capnopen\u00ae nebulizer device","volume":"22","author":"Akaishi","year":"2021","journal-title":"Am J Case Rep"},{"key":"2023063010592360000_znac284-B83","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/sajc.sajc_92_18","article-title":"Pressurized intraperitoneal aerosol chemotherapy procedure for nonresectable peritoneal carcinomatosis: first Indian study","volume":"8","author":"Somashekhar","year":"2019","journal-title":"South Asian J Cancer"},{"key":"2023063010592360000_znac284-B84","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40944-018-0193-x","article-title":"First Indian study on pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedure for advanced peritoneal carcinomatosis secondary to epithelial ovarian cancer","volume":"16","author":"Somashekhar","year":"2018","journal-title":"Indian J Gynecol Oncol"},{"key":"2023063010592360000_znac284-B85","doi-asserted-by":"crossref","first-page":"610572","DOI":"10.3389\/fonc.2020.610572","article-title":"Systemic chemotherapy including ramucirumab in combination with pressurized intra-peritoneal aerosol chemotherapy is a safe treatment option for peritoneal metastasis of gastric cancer","volume":"10","author":"Feldbr\u00fcgge","year":"2020","journal-title":"Front Oncol"},{"key":"2023063010592360000_znac284-B86","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ygyno.2013.11.022","article-title":"Activity of pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience","volume":"132","author":"Tempfer","year":"2014","journal-title":"Gynecol Oncol"},{"key":"2023063010592360000_znac284-B87","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.ejso.2018.04.020","article-title":"Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis","volume":"44","author":"Tempfer","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"2023063010592360000_znac284-B88","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1186\/s12885-016-2668-4","article-title":"Dynamic changes of tumor gene expression during repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC) in women with peritoneal cancer","volume":"16","author":"Rezniczek","year":"2016","journal-title":"BMC Cancer"},{"key":"2023063010592360000_znac284-B89","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/0300891619868013","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasized colorectal, appendiceal and small bowel cancer","volume":"106","author":"Gockel","year":"2020","journal-title":"Tumori"},{"key":"2023063010592360000_znac284-B90","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5230\/jgc.2018.18.e37","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in gastric cancer patients with peritoneal metastasis (PM): results of a single-center experience and register study","volume":"18","author":"Gockel","year":"2018","journal-title":"J Gastric Cancer"},{"key":"2023063010592360000_znac284-B91","doi-asserted-by":"crossref","first-page":"20180108","DOI":"10.1515\/pp-2018-0108","article-title":"Treatment of peritoneal carcinomatosis with pressurized intraperitoneal aerosol chemotherapy\u2014PIPAC-OPC2","volume":"3","author":"Graversen","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B92","doi-asserted-by":"crossref","DOI":"10.1177\/1758835918777036","article-title":"Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis","volume":"10","author":"Graversen","year":"2018","journal-title":"Ther Adv Med Oncol"},{"key":"2023063010592360000_znac284-B93","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejso.2019.08.024","article-title":"Pressurized intraperitoneal aerosol chemotherapy with one minute of electrostatic precipitation (ePIPAC) is feasible, but the histological tumor response in peritoneal metastasis is insufficient","volume":"46","author":"Graversen","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"2023063010592360000_znac284-B94","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jclinpath-2018-205683","article-title":"Detection of free intraperitoneal tumour cells in peritoneal lavage fluid from patients with peritoneal metastasis before and after treatment with pressurised intraperitoneal aerosol chemotherapy (PIPAC)","volume":"72","author":"Graversen","year":"2019","journal-title":"J Clin Pathol"},{"key":"2023063010592360000_znac284-B95","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.3390\/ijerph18115656","article-title":"Study protocol: phase I dose escalation study of oxaliplatin, cisplatin and doxorubicin applied as PIPAC in patients with peritoneal metastases","volume":"18","author":"Robella","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2023063010592360000_znac284-B96","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3389\/fphar.2019.00669","article-title":"Exploring the use of pegylated liposomal doxorubicin (Caelyx\u00ae) as pressurized intraperitoneal aerosol chemotherapy","volume":"10","author":"Robella","year":"2019","journal-title":"Front Pharmacol"},{"key":"2023063010592360000_znac284-B97","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12957-016-0892-7","article-title":"Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis","volume":"14","author":"Robella","year":"2016","journal-title":"World J Surg Oncol"},{"key":"2023063010592360000_znac284-B98","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1515\/pp-2016-0021","article-title":"Single-port access for pressurized intraperitoneal aerosol chemotherapy (PIPAC): technique, feasibility and safety","volume":"1","author":"Vaira","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B99","first-page":"2","article-title":"Safety and efficacy of pressurized intraperitoneal\/intrathoracic aerosol chemotherapy (PIPAC\/PITAC) in patients with peritoneal and\/or pleural carcinomatosis: a preliminary experience","volume":"2","author":"Kuchen","year":"2018","journal-title":"J Med Ther"},{"key":"2023063010592360000_znac284-B100","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12957-021-02357-5","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal malignancy: initial experience of the first program in the Baltic countries","volume":"19","author":"Ra\u010dkauskas","year":"2021","journal-title":"World J Surg Oncol"},{"key":"2023063010592360000_znac284-B101","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.suronc.2020.05.006","article-title":"Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): a bidirectional approach for gastric cancer peritoneal metastasis","volume":"34","author":"Di Giorgio","year":"2020","journal-title":"Surg Oncol"},{"key":"2023063010592360000_znac284-B102","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920940887","article-title":"Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cholangiocarcinoma","volume":"12","author":"Di Giorgio","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"2023063010592360000_znac284-B103","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s12885-018-4363-0","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for the treatment of malignant mesothelioma","volume":"18","author":"Giger-Pabst","year":"2018","journal-title":"BMC Cancer"},{"key":"2023063010592360000_znac284-B104","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.3802\/jgo.2017.28.e80","article-title":"Nutritional status, cachexia, and anorexia in women with peritoneal metastasis and intraperitoneal chemotherapy: a longitudinal analysis","volume":"28","author":"Hilal","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"2023063010592360000_znac284-B105","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11605-015-2995-9","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with low-dose cisplatin and doxorubicin in gastric peritoneal metastasis","volume":"20","author":"Nadiradze","year":"2016","journal-title":"J Gastrointest Surg"},{"key":"2023063010592360000_znac284-B106","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1245\/s10434-020-08743-9","article-title":"Systemic pharmacokinetics of oxaliplatin after intraperitoneal administration by electrostatic pressurized intraperitoneal aerosol chemotherapy (ePIPAC) in patients with unresectable colorectal peritoneal metastases in the CRC-PIPAC trial","volume":"28","author":"Lurvink","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2023063010592360000_znac284-B107","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.ejso.2019.06.018","article-title":"Safety and preliminary efficacy of electrostatic precipitation during pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable carcinomatosis","volume":"45","author":"Willaert","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"2023063010592360000_znac284-B108","doi-asserted-by":"crossref","first-page":"6852749","DOI":"10.1155\/2017\/6852749","article-title":"Feasibility and safety of pressurized intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis: a retrospective cohort study","volume":"2017","author":"H\u00fcbner","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"2023063010592360000_znac284-B109","first-page":"4596176","article-title":"Impact of pressurized intraperitoneal aerosol chemotherapy on quality of life and symptoms in patients with peritoneal carcinomatosis: a retrospective cohort study","volume":"2017","author":"Farinha","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"2023063010592360000_znac284-B110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7150\/jca.21460","article-title":"Inflammatory response and toxicity after pressurized intraperitoneal aerosol chemotherapy","volume":"9","author":"Farinha","year":"2018","journal-title":"J Cancer"},{"key":"2023063010592360000_znac284-B111","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.21873\/anticanres.13062","article-title":"No renal toxicity after repeated treatment with pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with unresectable peritoneal metastasis","volume":"38","author":"Larbre","year":"2018","journal-title":"Anticancer Res"},{"key":"2023063010592360000_znac284-B112","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1515\/pp-2016-0017","article-title":"Bidirectional chemotherapy in gastric cancer with peritoneal metastasis combining intravenous XELOX with intraperitoneal chemotherapy with low-dose cisplatin and doxorubicin administered as a pressurized aerosol: an open-label, phase-2 study (PIPAC-GA2)","volume":"1","author":"Khomyakov","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B113","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s13193-018-0771-5","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC): initial experience from Indian centers and a review of literature","volume":"10","author":"Katdare","year":"2019","journal-title":"Indian J Surg Oncol"},{"key":"2023063010592360000_znac284-B114","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1007\/s00464-020-07488-6","article-title":"Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center","volume":"34","author":"Ceribelli","year":"2020","journal-title":"Surg Endosc"},{"key":"2023063010592360000_znac284-B115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10585-020-10023-5","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study","volume":"37","author":"Elleb\u00e6k","year":"2020","journal-title":"Clin Exp Metastasis"},{"key":"2023063010592360000_znac284-B116","doi-asserted-by":"crossref","first-page":"20200109","DOI":"10.1515\/pp-2020-0109","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients","volume":"5","author":"Elleb\u00e6k","year":"2020","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B117","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/jclinpath-2020-206607","article-title":"Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated with PIPAC","volume":"74","author":"Nielsen","year":"2021","journal-title":"J Clin Pathol"},{"key":"2023063010592360000_znac284-B118","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1158\/1078-0432.CCR-20-2152","article-title":"PIPAC-OX: a phase I study of oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy in patients with peritoneal metastases","volume":"27","author":"Kim","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2023063010592360000_znac284-B119","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5114\/ada.2018.77096","article-title":"Overall clinical and trichoscopic analysis performed in patients who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis\u2014initial trial preliminary report","volume":"36","author":"Nowacki","year":"2019","journal-title":"Postepy Dermatol Alergol"},{"key":"2023063010592360000_znac284-B120","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1177\/0300060518778637","article-title":"The scientific report from the first pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures performed in the eastern part of Central Europe","volume":"46","author":"Nowacki","year":"2018","journal-title":"J Int Med Res"},{"key":"2023063010592360000_znac284-B121","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10585-018-9925-7","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of pancreas and biliary tract cancer","volume":"35","author":"Horvath","year":"2018","journal-title":"Clin Exp Metastasis"},{"key":"2023063010592360000_znac284-B122","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919846402","article-title":"Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C\/D) in patients with gastric cancer and peritoneal metastasis: a phase II study","volume":"11","author":"Struller","year":"2019","journal-title":"Ther Adv Med Oncol"},{"key":"2023063010592360000_znac284-B123","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/biomedicines8050102","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with oxaliplatin, cisplatin, and doxorubicin in patients with peritoneal carcinomatosis: an open-label, single-arm. phase II clinical trial","volume":"8","author":"De Simone","year":"2020","journal-title":"Biomedicines"},{"key":"2023063010592360000_znac284-B124","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1245\/s10434-021-10983-2","article-title":"Non-resectable malignant peritoneal mesothelioma treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) plus systemic chemotherapy could lead to secondary complete cytoreductive surgery: a cohort study","volume":"29","author":"Kepenekian","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"2023063010592360000_znac284-B125","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-021-00698-8","article-title":"Effect of pressurized intraperitoneal aerosol chemotherapy on the survival rate of patients with peritoneal carcinomatosis of gastric origin","author":"Tidadini","year":"2021","journal-title":"J Gastrointest Cancer"},{"key":"2023063010592360000_znac284-B126","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1007\/s00464-021-08802-6","article-title":"Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC)","volume":"36","author":"Lurvink","year":"2022","journal-title":"Surg Endosc"},{"key":"2023063010592360000_znac284-B127","doi-asserted-by":"crossref","first-page":"20180112","DOI":"10.1515\/pp-2018-0112","article-title":"Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane\u2122) for peritoneal carcinomatosis\u2014a phase I first-in-human study","volume":"3","author":"Van De Sande","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1245\/s10434-021-10505-0","article-title":"PIPAC for the treatment of gynecologic and gastrointestinal peritoneal metastases: technical and logistic considerations of a phase 1 trial","volume":"29","author":"Raoof","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"2023063010592360000_znac284-B129","doi-asserted-by":"crossref","first-page":"20180120","DOI":"10.1515\/pp-2018-0120","article-title":"Phase I\/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design","volume":"3","author":"Dumont","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B130","doi-asserted-by":"crossref","first-page":"20180118","DOI":"10.1515\/pp-2018-0118","article-title":"Study protocol: phase 1 dose escalating study of Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) with oxaliplatin in peritoneal metastasis","volume":"3","author":"Kim","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B131","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1515\/pp-2021-0132","article-title":"Can pressurised intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-O+) be added to standard treatment for resectable high-risk gastric cancer patients? a study protocol","volume":"6","author":"Reid","year":"2021","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B132","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12957-016-1008-0","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"14","author":"Girshally","year":"2016","journal-title":"World J Surg Oncol"},{"key":"2023063010592360000_znac284-B133","first-page":"6723","article-title":"Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin in women with peritoneal carcinomatosis: a cohort study","volume":"35","author":"Tempfer","year":"2015","journal-title":"Anticancer Res"},{"key":"2023063010592360000_znac284-B134","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ygyno.2015.02.009","article-title":"Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study","volume":"137","author":"Tempfer","year":"2015","journal-title":"Gynecol Oncol"},{"key":"2023063010592360000_znac284-B135","doi-asserted-by":"crossref","first-page":"e030408","DOI":"10.1136\/bmjopen-2019-030408","article-title":"Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC)","volume":"9","author":"Rovers","year":"2019","journal-title":"BMJ Open"},{"key":"2023063010592360000_znac284-B136","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1245\/s10434-020-09558-4","article-title":"Pressurized intraperitoneal aerosol chemotherapy (oxaliplatin) for unresectable colorectal peritoneal metastases: a multicenter, single-arm, phase II trial (CRC-PIPAC)","volume":"28","author":"Rovers","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2023063010592360000_znac284-B137","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejso.2020.05.021","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer","volume":"47","author":"Alyami","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"2023063010592360000_znac284-B138","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejso.2019.03.021","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in association with systemic chemotherapy and bevacizumab, evaluation of safety and feasibility. A single center comparative study","volume":"47","author":"Siebert","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"2023063010592360000_znac284-B139","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.ejso.2019.05.007","article-title":"Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: a multicenter study","volume":"45","author":"Sgarbura","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"2023063010592360000_znac284-B140","doi-asserted-by":"crossref","first-page":"20180107","DOI":"10.1515\/pp-2018-0107","article-title":"Adjuvant pressurized intraperitoneal aerosol chemotherapy (PIPAC) in resected high-risk colon cancer patients\u2014study protocol for the PIPAC-OPC3 Trial. A prospective, controlled phase 2 Study","volume":"3","author":"Graversen","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B141","doi-asserted-by":"crossref","first-page":"20180128","DOI":"10.1515\/pp-2018-0128","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as an outpatient procedure","volume":"3","author":"Graversen","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B142","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ejso.2018.02.014","article-title":"Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: an international survey study","volume":"44","author":"Nowacki","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"2023063010592360000_znac284-B143","doi-asserted-by":"crossref","first-page":"2743985","DOI":"10.1155\/2018\/2743985","article-title":"Feasibility, safety, and efficacy of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis: a registry study","volume":"2018","author":"Kurtz","year":"2018","journal-title":"Gastroenterol Res Pract"},{"key":"2023063010592360000_znac284-B144","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1245\/s10434-021-10860-y","article-title":"Clinical outcome for patients managed with low-dose cisplatin and doxorubicin delivered as pressurized intraperitoneal aerosol chemotherapy for unresectable peritoneal metastases of gastric cancer","volume":"29","author":"Sindayigaya","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"2023063010592360000_znac284-B145","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1245\/s10434-020-09508-0","article-title":"Pressurized intraperitoneal aerosol chemotherapy for colorectal peritoneal metastases","volume":"28","author":"Tabchouri","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2023063010592360000_znac284-B146","doi-asserted-by":"crossref","first-page":"20180111","DOI":"10.1515\/pp-2018-0111","article-title":"Pressurized intraperitoneal aerosol chemotherapy vs. intravenous chemotherapy for unresectable peritoneal metastases secondary to platinum resistant ovarian cancer\u2014study protocol for a randomized control trial","volume":"4","author":"Somashekhar","year":"2019","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B147","doi-asserted-by":"crossref","first-page":"20180110","DOI":"10.1515\/pp-2018-0110","article-title":"Randomized control trial comparing quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) and intravenous chemotherapy","volume":"3","author":"Somashekhar","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B148","first-page":"20180113","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo na\u00efve upper GI-adenocarcinomas with peritoneal seeding\u2014a phase II\/III trial of the AIO\/CAOGI\/ACO","volume":"3","author":"Goetze T","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B149","doi-asserted-by":"crossref","first-page":"20180114","DOI":"10.1515\/pp-2018-0114","article-title":"PIPAC-OV3: a multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer","volume":"3","author":"Bakrin","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B150","doi-asserted-by":"crossref","first-page":"20190010","DOI":"10.1515\/pp-2019-0010","article-title":"MESOTIP: phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy vs. systemic chemotherapy alone as 1st-line treatment of malignant peritoneal mesothelioma","volume":"4","author":"Sgarbura","year":"2019","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B151","doi-asserted-by":"crossref","first-page":"20180116","DOI":"10.1515\/pp-2018-0116","article-title":"PIPAC EstoK 01: pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin (PIPAC C\/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study","volume":"3","author":"Eveno","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"2023063010592360000_znac284-B152"}],"container-title":["British Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/110\/1\/10\/50749676\/znac284.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/110\/1\/10\/50749676\/znac284.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T11:01:11Z","timestamp":1688122871000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/110\/1\/10\/6691226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,3]]},"references-count":152,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,9,3]]},"published-print":{"date-parts":[[2022,12,13]]}},"URL":"https:\/\/doi.org\/10.1093\/bjs\/znac284","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,9,3]]}}}